Breakthrough discoveries identifying common genetic causes for amyotrophic lateral
sclerosis (ALS) and frontotemporal dementia (FTD) have transformed our view of these …

Despite mortality due to communicable diseases, poverty, and human conflicts, dementia
incidence is destined to increase in the developing world in tandem with the ageing …

In tandem with the ever‐increasing aging population in low and middle‐income countries,
the burden of dementia is rising on the African continent. Dementia prevalence varies from …

The first reports of disorders that in terms of cognitive and behavioral symptoms resemble
frontotemporal dementia (FTD) and in terms of motor symptoms resemble amyotrophic …

Frontotemporal lobar degeneration (FTLD) comprises a highly heterogeneous group of
disorders clinically associated with behavioral and personality changes, language …

Mutations in CHMP2B cause frontotemporal dementia (FTD) in a large Danish pedigree,
which is termed FTD linked to chromosome 3 (FTD-3), and also in an unrelated familial FTD …

The charged multivesicular body protein 2B gene (CHMP2B) was recently associated with
frontotemporal lobar degeneration (FTLD) linked to chromosome 3 in a Danish FTLD family …

Corticobasal syndrome (CBS) is a rare cognitive and movement disorder characterized by
asymmetric rigidity, apraxia, alien-limb phenomenon, cortical sensory loss, myoclonus, focal …

Mutations in coding and non-coding regions of FUS cause amyotrophic lateral sclerosis
(ALS). The latter mutations may exert toxicity by increasing FUS accumulation. We show …

TAR DNA‐binding protein‐43 KDa (TDP‐43) and fused in sarcoma (FUS) as the defining
pathological hallmarks for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia …